Institut Gustave Roussy

Paris 94805 Villejuif

4 studies enrolling now · 11 studies all time

What they study most

Advanced Solid Tumor, Advanced/Metastatic Solid Tumors, Colorectal Cancer, Differentiated Thyroid Cancer (DTC), Esophageal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, Gastrointestinal Stromal Tumors (GIST), HNSCC, Head and Neck Squamous Cell Carcinoma, MTAP-deleted Solid Tumors, Melanoma

Studies at this site

• A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors — Recruiting now
• A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies — Recruiting now
• A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer — Recruiting now
• Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors — Recruiting now
• S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP — Running, not enrolling
• Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma — Stopped early
• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) — Running, not enrolling
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) — Stopped early
• Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma — Completed
• (NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors — Completed
• The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors — Completed